NasdaqGM:MTBC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

MTBC, Inc., a healthcare information technology (IT) company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. More Details


Snowflake Analysis

Excellent balance sheet and fair value.


Similar Companies

Share Price & News

How has MTBC's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MTBC's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-3.1%

MTBC

-2.9%

US Healthcare Services

-1.4%

US Market


1 Year Return

126.3%

MTBC

73.5%

US Healthcare Services

17.8%

US Market

Return vs Industry: MTBC exceeded the US Healthcare Services industry which returned 77.1% over the past year.

Return vs Market: MTBC exceeded the US Market which returned 18.5% over the past year.


Shareholder returns

MTBCIndustryMarket
7 Day-3.1%-2.9%-1.4%
30 Day-1.1%7.9%4.7%
90 Day-13.5%9.2%8.2%
1 Year126.3%126.3%74.0%73.5%20.5%17.8%
3 Year195.6%195.6%111.8%110.2%42.2%32.7%
5 Year457.1%457.1%162.5%159.7%83.4%62.7%

Price Volatility Vs. Market

How volatile is MTBC's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MTBC undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MTBC ($8.69) is trading below our estimate of fair value ($193.7)

Significantly Below Fair Value: MTBC is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MTBC is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: MTBC is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MTBC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MTBC is good value based on its PB Ratio (1.4x) compared to the US Healthcare Services industry average (5.5x).


Next Steps

Future Growth

How is MTBC forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

63.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MTBC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MTBC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MTBC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MTBC's revenue (25.1% per year) is forecast to grow faster than the US market (10.1% per year).

High Growth Revenue: MTBC's revenue (25.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MTBC's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has MTBC performed over the past 5 years?

-11.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MTBC is currently unprofitable.

Growing Profit Margin: MTBC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MTBC is unprofitable, and losses have increased over the past 5 years at a rate of 11.3% per year.

Accelerating Growth: Unable to compare MTBC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MTBC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).


Return on Equity

High ROE: MTBC has a negative Return on Equity (-8.95%), as it is currently unprofitable.


Next Steps

Financial Health

How is MTBC's financial position?


Financial Position Analysis

Short Term Liabilities: MTBC's short term assets ($31.0M) exceed its short term liabilities ($28.3M).

Long Term Liabilities: MTBC's short term assets ($31.0M) exceed its long term liabilities ($18.3M).


Debt to Equity History and Analysis

Debt Level: MTBC's debt to equity ratio (12.5%) is considered satisfactory.

Reducing Debt: MTBC's debt to equity ratio has reduced from 29.3% to 12.5% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MTBC has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if MTBC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is MTBC current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MTBC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MTBC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MTBC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MTBC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MTBC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.7yrs

Average management tenure


CEO

Stephen Snyder (43 yo)

2.75yrs

Tenure

US$1,145,180

Compensation

Mr. Stephen A. Snyder has been Chief Executive Officer of MTBC Inc. since January 01, 2018. Mr. Snyder serves as Director at CareCloud Corporation since 2020. Mr. Snyder served as the President of MTBC Inc ...


CEO Compensation Analysis

Compensation vs Market: Stephen's total compensation ($USD1.15M) is above average for companies of similar size in the US market ($USD589.00K).

Compensation vs Earnings: Stephen's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Stephen Snyder
CEO & Director2.75yrsUS$1.15m1.67%
$ 1.8m
A. Chaudhry
President & Director1.5yrsUS$704.37k0.56%
$ 617.0k
Bill Korn
Chief Financial Officer7.25yrsUS$862.48k1.07%
$ 1.2m
Norman Roth
Principal Accounting Officer & Controllerno datano data0.45%
$ 498.6k
Kimberly Blanche
General Counsel0.67yrno data0%
$ 0
Nathalie Garcia
Chief Compliance Officer & Corporate Counsel0.75yrno datano data
Wesley Stolp
Executive Vice President of Sales0.50yrno datano data
Mike Cuesta
Chief Marketing Officer0.50yrno datano data
Elizabeth Ferrer
Vice President of Human Resources0.17yrno datano data
Loraine Goetsch
Division Presidentno datano datano data
Shruti Patel
President of Telehealth Division & Director of Compliance0.67yrno datano data
Jonathan Bertman
Chief Medical Officer1.08yrsno datano data

0.7yrs

Average Tenure

43yo

Average Age

Experienced Management: MTBC's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Stephen Snyder
CEO & Director2.75yrsUS$1.15m1.67%
$ 1.8m
A. Chaudhry
President & Director1.5yrsUS$704.37k0.56%
$ 617.0k
Anne Busquet
Independent Director6.25yrsUS$190.62k1.5%
$ 1.7m
Mahmud Haq
Founder & Executive Chairman19.75yrsUS$1.01m36.84%
$ 40.7m
Cameron Munter
Independent Director7.33yrsUS$190.62k0.99%
$ 1.1m
John Daly
Independent Director6.83yrsUS$190.62k0.76%
$ 838.0k
Lawrence Sharnak
Independent Director0.50yrno data0.039%
$ 43.5k

6.8yrs

Average Tenure

63.5yo

Average Age

Experienced Board: MTBC's board of directors are considered experienced (6.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: MTBC insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.5%.


Top Shareholders

Company Information

MTBC, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MTBC, Inc.
  • Ticker: MTBC
  • Exchange: NasdaqGM
  • Founded: 1999
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$110.365m
  • Shares outstanding: 12.70m
  • Website: https://www.mtbc.com

Number of Employees


Location

  • MTBC, Inc.
  • 7 Clyde Road
  • Somerset
  • New Jersey
  • 8873
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MTBCNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJul 2014
MTBDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2014
MTBC.PNasdaqGM (Nasdaq Global Market)11% CUM PFD CL AUSUSDNov 2015

Biography

MTBC, Inc., a healthcare information technology (IT) company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The c ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/22 01:01
End of Day Share Price2020/10/21 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.